RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Farin Kamangar to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Farin Kamangar has written about Drug Therapy, Combination.
Farin Kamangar
Connection Strength
0.018
Drug Therapy, Combination
  1. Qu CX, Kamangar F, Fan JH, Yu B, Sun XD, Taylor PR, Chen BE, Abnet CC, Qiao YL, Mark SD, Dawsey SM. Chemoprevention of primary liver cancer: a randomized, double-blind trial in Linxian, China. J Natl Cancer Inst. 2007 Aug 15; 99(16):1240-7.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support